Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality Incentive Program. Final Rule

Area of Science:

• Health Policy
• Nephrology
• Healthcare Management

Background:

• The End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) requires regular updates to reflect current healthcare costs and quality metrics.
• Accurate Medicare reimbursement is crucial for the financial viability of ESRD facilities providing essential outpatient maintenance dialysis treatments.

Purpose of the Study:

• To outline revisions to the ESRD Prospective Payment System (PPS) for calendar year (CY) 2016.
• To establish updated payment rates ensuring accurate Medicare reimbursement for ESRD facilities.
• To define requirements for the ESRD Quality Incentive Program (QIP) for program years (PYs) 2017 through 2019.

Main Methods:

• Rulemaking process involving updates and revisions to existing payment and quality programs.
• Analysis of healthcare costs and quality indicators relevant to outpatient maintenance dialysis.
• Specification of program requirements and performance metrics for the ESRD Quality Incentive Program.

Main Results:

• Implementation of revised payment amounts under the ESRD PPS for CY 2016.
• Establishment of updated quality metrics and payment adjustments for the ESRD QIP for PYs 2017-2019.
• Ensured continued accurate Medicare payments for ESRD facilities.

Conclusions:

• The updated rule supports accurate financial compensation for ESRD facilities.
• The revisions enhance the ESRD Quality Incentive Program, promoting higher quality patient care.
• This regulatory update is vital for the sustainable operation of dialysis services nationwide.